Adial Pharmaceuticals, Inc. (ADIL): Cash & Equivalents
$5.88M
As of 2025-12-31
+13.7%
3-year compound annual growth
+6.0%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.88M | +56.8% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $3.75M | +32.7% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $2.83M | -29.4% | 2025-03-04, Balance as of period end |
| 2022-12-31 | $4.00M | -34.0% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $6.06M | +37.7% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $4.40M | -35.1% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $6.78M | +75.2% | 2021-03-22, Balance as of period end |
| 2018-12-31 | $3.87M | n/m | 2020-03-20, Balance as of period end |
| 2017-12-31 | $18.2K | n/a | 2019-02-19, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | 2025-12-31 | $5.88M | +56.8% |
| Kairos Pharma, Ltd. (KAPA) | 2025-12-31 | $4.49M | +253.1% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $4.98M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $3.06M | -16.8% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $1.8K | -16.3% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.09M | -44.0% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $4.00M | -45.1% |
| Greenwich LifeSciences, Inc. (GLSI) | 2025-12-31 | $6.18M | +51.0% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $4.31M | +23.1% |
Compare ADIL, KAPA, HIND, SER side by side · Screen every company in Pharmaceutical Preparations ↗